Search PubMed⌕ Search

Biomedical subjects

D F Milam

Publications and source records attributed to D F Milam.

56 records · Page 4Linked to original sources

Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver.

14C-Benzidine (BZ) was added to the recirculating perfusate of the isolated perfused rat liver. The system was monitored at timed intervals for the disappearance of BZ and the appearance of metabolites. BZ was extensively metabolized by this system and after 2 hr of perfusion greater than 95% of the administered radiolabel was in the form of metabolic products. In the perfusate the concentration of BZ declined rapidly whereas the concentration of N-acetyl-BZ (ABZ) increased temporarily and then declined. The concentration of N,N'-diacetyl-BZ (DABZ) increased with time and by 1 hr DABZ had become the major metabolite in the system. In the bile, which contained 22% of the dose after 2 hr, BZ-N-glucuronide and ABZ-glucuronide were the major metabolites initially, but after 1 hr of perfusion N-hydroxy-DABZ-glucuronide had become the major biliary metabolite. Addition of BZ and 35S-Na2SO4 to the perfusate resulted in at least one 35S-containing metabolite. Other major metabolites excreted in bile included 3-hydroxy-DABZ glucuronide, ABZ, and DABZ. DABZ underwent deacetylation to ABZ and N-hydroxy-DABZ underwent rapid reduction to DABZ when added to the isolated liver system. Qualitatively similar biliary metabolite patterns at later times were observed when either BZ, DABZ, or N-hydroxy-DABZ was added to the perfusate.

Animals↗

Metabolism, distribution, and excretion of the carcinogenic aromatic amine, 3,3'-dimethoxybenzidine in the rat. Formation of mutagenic urinary and biliary metabolites.

The carcinogenic aromatic amine 3,3'-dimethoxybenzidine (DMOB) was rapidly metabolized in the rat. Thirty minutes after iv administration of 14C-DMOB, less than 2% of the dose could be recovered from the animal as the parent compound. Extensive biliary excretion (70% of the dose) resulted in the accumulation of approximately 50% of the dose in the intestinal tract. Three days after either oral or iv dosing, 50% of the administered radiolabel had been excreted in the feces and 30-40% excreted in the urine while 45% of the radiolabel remaining in the animal was present in the liver in the form of covalently bound metabolites. GC/MS studies of urine and bile demonstrated the presence of eight previously unidentified metabolites formed via N-acetylation, hydroxylation, O-demethylation, and glucuronidation. DMOB was mutagenic to Salmonella typhimurium strain TA98 only after metabolic activation by liver enzymes. N-Acetyl-DMOB was a more potent bacterial mutagen than either DMOB, N,N'-diacetyl-DMOB, or other biliary metabolites.

Animals↗